Literature DB >> 9108669

Role of tissue specific alternative pre-mRNA splicing in the differentiation of the erythrocyte membrane.

E J Benz1, S C Huang.   

Abstract

Regulated alternative pre-mRNA splicing is neither as widely appreciated as a fundamental aspect of controlled gene expression nor as thoroughly studied as transcriptional regulation. However, as exemplified by the phenomena cited in this review, alternative splicing is a fundamentally important mechanism used in the eukaryotic world to enhance the range, versatility and plasticity of the structural information contained within a gene, and to create additional strategies by which the net quantitative output of a given gene product can be controlled. Regulation of RNA splicing gives genes a modularity that adds flexibility, and, therefore, selective advantage, to eukaryotes. It is likely, though unproven, that this opportunity for refined regulation and diversification provides at least one basis for the existence of the tandem exon-intron-exon structure found in the vast majority of eukaryotic genes and many viral genes. Many examples of alternative splicing are known, but, for the majority, no obvious biological impact of the alternatively spliced proteins on known cellular functions can be appreciated. Examples by which selectively regulated splicing pathways alter both the physiology and pathology of a major cellular event, such as differentiation and mechanical function of the red cell membrane, are thus relatively rare. The protein 4.1 gene and mRNA products thus provide an instructive and unusual system in which to explore the broader issue of the role of these regulatory mechanisms in the overall scheme of gene regulation and adaptation. The fact that hereditary hemolytic anemias result from mutations that directly or indirectly disrupt the splicing system emphasized the relevance of these mechanisms to molecular medicine. The features of splicing that we have reviewed in this paper, and the specific impact that regulated splicing exerts on differentiating red cells have, we hope, convinced the reader that RNA splicing is an important, fascinating, and potentially fruitful area for future study of human disease processes.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9108669      PMCID: PMC2376591     

Source DB:  PubMed          Journal:  Trans Am Clin Climatol Assoc        ISSN: 0065-7778


  33 in total

1.  Antisense RNA inhibits expression of membrane skeleton protein 4.1 during embryonic development of Xenopus.

Authors:  D H Giebelhaus; D W Eib; R T Moon
Journal:  Cell       Date:  1988-05-20       Impact factor: 41.582

2.  Tissue-specific analogues of erythrocyte protein 4.1 retain functional domains.

Authors:  R A Anderson; I Correas; C Mazzucco; J D Castle; V T Marchesi
Journal:  J Cell Biochem       Date:  1988-07       Impact factor: 4.429

3.  Selective expression of an erythroid-specific isoform of protein 4.1.

Authors:  T K Tang; T L Leto; I Correas; M A Alonso; V T Marchesi; E J Benz
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

4.  Multiple protein 4.1 isoforms produced by alternative splicing in human erythroid cells.

Authors:  J G Conboy; J Chan; N Mohandas; Y W Kan
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

5.  A protein immunologically related to erythrocyte band 4.1 is found on stress fibres on non-erythroid cells.

Authors:  C M Cohen; S F Foley; C Korsgren
Journal:  Nature       Date:  1982-10-14       Impact factor: 49.962

Review 6.  Sex in flies: the splice of life.

Authors:  B S Baker
Journal:  Nature       Date:  1989-08-17       Impact factor: 49.962

7.  Regulated expression of multiple chicken erythroid membrane skeletal protein 4.1 variants is governed by differential RNA processing and translational control.

Authors:  J Ngai; J H Stack; R T Moon; E Lazarides
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

8.  Mechanisms of cytoskeletal regulation: modulation of aortic endothelial cell protein band 4.1 by the extracellular matrix.

Authors:  T L Leto; B M Pratt; J A Madri
Journal:  J Cell Physiol       Date:  1986-06       Impact factor: 6.384

9.  Identification of the functional site of erythrocyte protein 4.1 involved in spectrin-actin associations.

Authors:  I Correas; T L Leto; D W Speicher; V T Marchesi
Journal:  J Biol Chem       Date:  1986-03-05       Impact factor: 5.157

10.  Asynchronous regulation of splicing events within protein 4.1 pre-mRNA during erythroid differentiation.

Authors:  F Baklouti; S C Huang; T K Tang; J Delaunay; V T Marchesi; E J Benz
Journal:  Blood       Date:  1996-05-01       Impact factor: 22.113

View more
  1 in total

1.  Alternative splicing as a therapeutic target for human diseases.

Authors:  Kenneth J Dery; Veronica Gusti; Shikha Gaur; John E Shively; Yun Yen; Rajesh K Gaur
Journal:  Methods Mol Biol       Date:  2009
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.